Cap
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
Claims
The ornamental design for a cap, as shown and described.
Referenced Cited
Patent History
Patent number: D552992
Type: Grant
Filed: Oct 5, 2005
Date of Patent: Oct 16, 2007
Assignee: Glaxo Group Limited (Middlesex)
Inventor: Gary Spencer (London)
Primary Examiner: Robert M. Spear
Assistant Examiner: Susan Bennett Hattan
Attorney: Nora Stein-Fernandez
Application Number: 29/239,862
Type: Grant
Filed: Oct 5, 2005
Date of Patent: Oct 16, 2007
Assignee: Glaxo Group Limited (Middlesex)
Inventor: Gary Spencer (London)
Primary Examiner: Robert M. Spear
Assistant Examiner: Susan Bennett Hattan
Attorney: Nora Stein-Fernandez
Application Number: 29/239,862
Classifications
Current U.S. Class:
D9/454